Independent register of U.S. FDA drug recalls · updated Oct 10, 2026
RxRecalls Get alerts

FDA Drug Recalls

635 recalls, newest first

Class II · Moderate risk

L-Cysteine Hydrochloride Injection

Lack of Assurance of Sterility: a recent FDA inspection at the manufacturing firm raised concerns that the product sterility may be compromised.

Terminated Sterility / contamination Sandoz Inc NDC 66758-005-01 D-0141-2017
Class II · Moderate risk

L-Cysteine Hydrochloride Injection

Lack of Assurance of Sterility: a recent FDA inspection at the manufacturing firm raised concerns that the product sterility may be compromised.

Terminated Sterility / contamination Sandoz Inc NDC 66758-004-01 D-0140-2017
Class II · Moderate risk

Papa/Phen/Prost

Lack of Assurance of Sterility: product produced on a day there was an excursion in environmental monitoring data.

Terminated Sterility / contamination Fallon Wellness Pharmacy, L.L.C. D-0174-2017
Class II · Moderate risk

Papa/Phen/Prost

Lack of Assurance of Sterility: product produced on a day there was an excursion in environmental monitoring data.

Terminated Sterility / contamination Fallon Wellness Pharmacy, L.L.C. D-0173-2017
Class II · Moderate risk

Succinylcholine Chloride

Lack of Assurance of Sterility: A portion of the batch quantity was compounded outside of the firm's process media validation.

Terminated Sterility / contamination Pharmedium Services, LLC NDC 61553-0364-65 D-0125-2017

Recalls by year